Rational design of anti-GITR-based combination immunotherapy
Zappasodi et al.
Nature Medicine
April 2019
Authors and Affiliates
Zappasodi R1,2, Sirard C3, Li Y1,2, Budhu S1, Abu-Akeel M1, Liu C1, Yang X1, Zhong H1, Newman W3, Qi J2,4, Wong P2,4, Schaer D1, Koon H5, Velcheti V6, Hellmann MD2,7,8, Postow MA7,8, Callahan MK2,7,8, Wolchok JD9,10,11,12, Merghoub T13,14,15;
Author information
1
Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Leap Therapeutics, Cambridge, MA, USA.
4
Immune Monitoring Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5
Case Western Reserve University, Cleveland, OH, USA.
6
Department of Hematology and Oncology, New York University School of Medicine, New York, NY, USA.
7
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
8
Weill Cornell Medical College, New York, NY, USA.
9
Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA. wolchokj@mskcc.org.
10
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. wolchokj@mskcc.org.
11
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. wolchokj@mskcc.org.
12
Weill Cornell Medical College, New York, NY, USA. wolchokj@mskcc.org.
13
Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA. merghout@mskcc.org.
14
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. merghout@mskcc.org.
15
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. merghout@mskcc.org.